Optogenetic Silencing of Hypocretin/Orexin Neurons Using Transgenic Expression of a Light-Driven Proton Pump

Citation

Williams, R. H., Chen, T. M., Tsunematsu, T., Yamanaka, A., & Kilduff, T. S. (2013, 9-13 November). Optogenetic silencing of hypocretin/orexin neurons using transgenic expression of a light-driven proton pump. Paper presented at the Neuroscience 2013, San Diego, CA.

Abstract

Hypocretin/orexin (Hcrt) neurons are integral for maintenance of arousal. Although optogenetic tools have been used to investigate Hcrt circuitry, prolonged inhibition of Hcrt-mediated behavior has been problematic. We generated orexin/Arch transgenic mice in which the prepro-orexin promoter drives expression of eGFP as well as modified archaerhodopsin-3 (Arch), a neuronal silencer activated by yellow light. Arch encodes a light-activated proton pump that causes cellular hyperpolarization and produces more substantial currents at lower irradiance levels than halorhodopsin. Thus, Arch may be better suited for long-term circuit inhibition, and may serve as an important tool for deciphering the role of Hcrt signaling in the maintenance of wakefulness.


Read more from SRI

  • Banner and attendees at the IEEE Hard Tech Venture Summit

    Cultivating hard tech startups that scale

    IEEE’s Hard Tech Venture Summit convened innovators at SRI to refine strategies and build new networks.

  • Patient going into a MRI

    Bringing surgical tools inside the MRI

    Drawing on SRI’s unique innovation ecosystem, the startup Medical Devices Corner is seeking to improve cancer surgery by advancing MRI-safe teleoperation.

  • Christopher Mims and Susan Patrick

    PARC Forum: How to AI

    The Wall Street Journal tech columnist Christopher Mims and SRI Education’s Susan Patrick discuss how AI can strengthen human agency.